Ranitidine Replacement and GERD Treatment Guidelines

Alternative H2-Receptor Antagonists

The American Academy of Pediatrics recommends famotidine 1 mg/kg/day divided in 2 doses for pediatric patients ages 1-16 years who were previously on ranitidine, as it is FDA-approved and well-tolerated 2
Famotidine is 20-50 times more potent than cimetidine and does not have the contamination issues that affected ranitidine, making it a preferred replacement for ranitidine 1
Famotidine does not interfere with the cytochrome P-450 system, making it safer for patients on multiple medications, including clopidogrel 1

The American Gastroenterological Association recommends proton pump inhibitors (PPIs) as first-line therapy for most GERD patients, rather than H2-receptor antagonists, due to their greater effectiveness in symptom control and healing of erosive esophagitis 3, 4
Standard-dose PPIs once daily should be tried initially, with an increase to twice-daily PPI dosing if inadequate response after 2-4 weeks 3
H2-receptor antagonists, such as famotidine, can be reserved for mild, intermittent symptoms or as adjunctive nocturnal therapy 5

Tachyphylaxis develops within 6 weeks of continuous use of H2-receptor antagonists, limiting their long-term effectiveness 1, 5
Standard doses of H2-receptor antagonists reduce duodenal but not gastric ulcers in NSAID users, highlighting their limitations in certain patient populations 6, 1

The American College of Cardiology recommends avoiding prolonged H2-receptor antagonist monotherapy due to tachyphylaxis, and switching to PPIs if symptoms persist beyond 4-6 weeks 1, 5
For patients on dual antiplatelet therapy, famotidine is preferred over PPIs to avoid drug interactions, according to the American Heart Association 1